Literature DB >> 21220778

Immune dysregulation and vascular risk in HIV-infected patients: implications for clinical care.

Virginia A Triant1, Steven K Grinspoon.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21220778      PMCID： PMC3071222          DOI： 10.1093/infdis/jiq084

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  20 in total

1.  Early immune senescence in HIV disease.

Authors:  Seema Desai; Alan Landay
Journal:  Curr HIV/AIDS Rep       Date:  2010-02       Impact factor: 5.071

2.  Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men.

Authors:  Janet Lo; Suhny Abbara; Leon Shturman; Anand Soni; Jeffrey Wei; Jose A Rocha-Filho; Khurram Nasir; Steven K Grinspoon
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

3.  Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men.

Authors:  Robert C Kaplan; Lawrence A Kingsley; Stephen J Gange; Lorie Benning; Lisa P Jacobson; Jason Lazar; Kathryn Anastos; Phyllis C Tien; A Richey Sharrett; Howard N Hodis
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

4.  Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease.

Authors:  Virginia A Triant; Hang Lee; Colleen Hadigan; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2007-04-24       Impact factor: 5.958

5.  Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study.

Authors:  Carl Grunfeld; Joseph A C Delaney; Christine Wanke; Judith S Currier; Rebecca Scherzer; Mary L Biggs; Phyllis C Tien; Michael G Shlipak; Stephen Sidney; Joseph F Polak; Daniel O'Leary; Peter Bacchetti; Richard A Kronmal
Journal:  AIDS       Date:  2009-09-10       Impact factor: 4.177

6.  Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis.

Authors:  Priscilla Y Hsue; Peter W Hunt; Amanda Schnell; S Craig Kalapus; Rebecca Hoh; Peter Ganz; Jeffrey N Martin; Steven G Deeks
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

7.  The association between the receipt of lipid lowering therapy and HIV status among veterans who met NCEP/ATP III criteria for the receipt of lipid lowering medication.

Authors:  Matthew S Freiberg; David A Leaf; Joseph L Goulet; Matthew B Goetz; Krisann K Oursler; Cynthia L Gibert; Maria C Rodriguez-Barradas; Adeel A Butt; Amy C Justice
Journal:  J Gen Intern Med       Date:  2009-01-06       Impact factor: 5.128

8.  Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.

Authors:  Signe Westring Worm; Caroline Sabin; Rainer Weber; Peter Reiss; Wafaa El-Sadr; Francois Dabis; Stephane De Wit; Matthew Law; Antonella D'Arminio Monforte; Nina Friis-Møller; Ole Kirk; Eric Fontas; Ian Weller; Andrew Phillips; Jens Lundgren
Journal:  J Infect Dis       Date:  2010-02-01       Impact factor: 5.226

9.  Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial.

Authors:  Andrew N Phillips; Andrew Carr; Jacquie Neuhaus; Fehmida Visnegarwala; Ronald Prineas; William J Burman; Ian Williams; Fraser Drummond; Daniel Duprez; Waldo H Belloso; Frank-Detlef Goebel; Birgit Grund; Angelos Hatzakis; Jose Vera; Jens D Lundgren
Journal:  Antivir Ther       Date:  2008

10.  Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Authors:  Lewis H Kuller; Russell Tracy; Waldo Belloso; Stephane De Wit; Fraser Drummond; H Clifford Lane; Bruno Ledergerber; Jens Lundgren; Jacqueline Neuhaus; Daniel Nixon; Nicholas I Paton; James D Neaton
Journal:  PLoS Med       Date:  2008-10-21       Impact factor: 11.069
View more
  10 in total

1.  Undetectable = Untransmittable and Your Health: The Personal Benefits of Early and Continuous Therapy for HIV Infection.

Authors:  Mark J Siedner; Virginia Triant
Journal:  J Infect Dis       Date:  2019-01-07       Impact factor: 5.226

2.  Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.

Authors:  Virginia A Triant; Jeremiah Perez; Susan Regan; Joseph M Massaro; James B Meigs; Steven K Grinspoon; Ralph B D'Agostino
Journal:  Circulation       Date:  2018-02-14       Impact factor: 29.690

3.  Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus.

Authors:  Kunjal Patel; Jiajia Wang; Denise L Jacobson; Steven E Lipshultz; David C Landy; Mitchell E Geffner; Linda A Dimeglio; George R Seage; Paige L Williams; Russell B Van Dyke; George K Siberry; William T Shearer; Luciana Young; Gwendolyn B Scott; James D Wilkinson; Stacy D Fisher; Thomas J Starc; Tracie L Miller
Journal:  Circulation       Date:  2013-12-23       Impact factor: 29.690

4.  Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy.

Authors:  Mark J Siedner; June-Ho Kim; Ruth Sentongo Nakku; Prossy Bibangambah; Linda Hemphill; Virginia A Triant; Jessica E Haberer; Jeffrey N Martin; A Rain Mocello; Yap Boum; Douglas S Kwon; Russell P Tracy; Tricia Burdo; Yong Huang; Huyen Cao; Samson Okello; David R Bangsberg; Peter W Hunt
Journal:  J Infect Dis       Date:  2015-09-07       Impact factor: 5.226

5.  Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment.

Authors:  Robert C Kaplan; Alan L Landay; Howard N Hodis; Stephen J Gange; Philip J Norris; Mary Young; Kathryn Anastos; Phyllis C Tien; Xiaonan Xue; Jason Lazar; Christina M Parrinello; Lorie Benning; Russell P Tracy
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-01       Impact factor: 3.731

Review 6.  HIV-associated large-vessel vasculopathy: a review of the current and emerging clinicopathological spectrum in vascular surgical practice.

Authors:  Balasoobramanien Pillay; Pratistadevi K Ramdial; Datshana P Naidoo
Journal:  Cardiovasc J Afr       Date:  2015 Mar-Apr       Impact factor: 1.167

Review 7.  HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation.

Authors:  David B Gootenberg; Jeffrey M Paer; Jesus-Mario Luevano; Douglas S Kwon
Journal:  Curr Opin Infect Dis       Date:  2017-02       Impact factor: 4.915

Review 8.  HIV infection and stroke: current perspectives and future directions.

Authors:  Laura A Benjamin; Alan Bryer; Hedley C A Emsley; Saye Khoo; Tom Solomon; Myles D Connor
Journal:  Lancet Neurol       Date:  2012-10       Impact factor: 44.182

9.  Immune activation in HIV-infected aging women on antiretrovirals--implications for age-associated comorbidities: a cross-sectional pilot study.

Authors:  Maria L Alcaide; Anita Parmigiani; Suresh Pallikkuth; Margaret Roach; Riccardo Freguja; Marina Della Negra; Hector Bolivar; Margaret A Fischl; Savita Pahwa
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

10.  Hepatic, Renal, Hematologic, and Inflammatory Markers in HIV-Infected Children on Long-term Suppressive Antiretroviral Therapy.

Authors:  Ann J Melvin; Meredith Warshaw; Alexandra Compagnucci; Yacine Saidi; Linda Harrison; Anna Turkova; Gareth Tudor-Williams
Journal:  J Pediatric Infect Dis Soc       Date:  2017-09-01       Impact factor: 3.164
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.